Literature DB >> 16107957

Suppressor alphabeta T lymphocytes control innate resistance to endotoxic shock.

Jessica Jones-Carson1, Giamila Fantuzzi, Britta Siegmund, Charles Dinarello, Kevin J Tracey, Haichao Wang, Ferric C Fang, Andres Vazquez-Torres.   

Abstract

A considerable amount of research has focused on elucidating the mechanisms by which cytokines synthesized by cells of the innate immune system participate in the life-threatening multiple-organ failure of endotoxic shock. We show here that alphabeta T cells, which are archetypes of the adaptive cellular immune response, suppress the proinflammatory cascade triggered during the early stages of lipopolysaccharide (LPS)-induced endotoxemia. The absence of alphabeta T cells led to the fulminant death of LPS-challenged mice, coinciding with a massive release of the proinflammatory cytokines tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma and a marked reduction in the synthesis of the immunosuppressive cytokine transforming growth factor (TGF)-beta. Cytotoxic T lymphocyte antigen (CTLA)-positive alphabeta T cells emerging shortly after LPS challenge appear to control TGF-beta synthesis. The neutralization of either TGF-beta or CTLA4 resulted in similar increases in IFN-gamma and TNF-alpha serum concentrations in LPS-challenged mice. These observations suggest that suppressor alphabeta T lymphocytes protect against the proinflammatory cascade unleashed during the innate stages of endotoxemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107957     DOI: 10.1086/432727

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Changes in intestinal mucosal immune barrier in rats with endotoxemia.

Authors:  Chong Liu; Ang Li; Yi-Bing Weng; Mei-Li Duan; Bao-En Wang; Shu-Wen Zhang
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

2.  A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1.

Authors:  Jie Zhang; Muh Geot Wong; May Wong; Simon Gross; Jason Chen; Carol Pollock; Sonia Saad
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.